跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIZO-PF BIMATOTIM 0.3/5 - TGA Drug Approval Details
Approvals
/
TGA
/
VIZO-PF BIMATOTIM 0.3/5
Approved
STANDARD
VIZO-PF BIMATOTIM 0.3/5
AFT Pharmaceuticals Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ad4acd17807dbd62
Company
AFT Pharmaceuticals Pty Ltd
Type
Standard
Approval Details
Approval Id
ad4acd17807dbd62
Product Name
VIZO-PF BIMATOTIM 0.3/5
Artg Id
336897
Artg Name
VIZO-PF BIMATOTIM 0.3/5 bimatoprost 300 microgram/mL & timolol (as maleate) 5 mg/mL eye drop solution bottle
Sponsor
AFT Pharmaceuticals Pty Ltd
Company Detail Path
/organization/aft-pharmaceuticals-au-pty-ltd
Artg Date
2021-08-12
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/27a5b4d297c4b3019baee97616341d01.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8c4abfadf080d0613cc2c68007a66c7f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ad4acd17807dbd62
Type
Standard
Back to TGA Approvals